Proteins are an important class of biological macromolecules composed of amino acids present in living organisms. They play a variety of important roles, including participating in the metabolism, transportation, and transmission of nerve impulses in the body in organisms, and they are important molecules necessary to maintain life activities. Peptides are proteins of low molecular weight, usually consisting of less than 50 amino acid residues. Similar to proteins, peptides also play various important biological roles.
Ace Therapeutics offers hundreds of natural and recombinant proteins & peptides for stroke research, including but not limited to, cytokines, neuroprotective proteins, apoptotic factors, and inflammatory mediators.
Importantly, each of our products is verified by standard quality control procedures and tested for biological activity and low endotoxicity.
Please access our all-series proteins & peptides or contact our scientist for personalized assistance.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ACPP-1256 | Bestrophin Blocking Peptide (AC1256) | 250 µg |
Bestrophin Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg |
MC4 Receptor Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg |
Pannexin 1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1259 | Usherin Blocking Peptide (AC1259) | 250 µg |
Usherin Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg |
iNOS Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1261 | TSH beta Blocking Peptide (AC1261) | 250 µg |
TSH beta Blocking Peptide for Immunocompeition, Immunodepletion
|
inquiry |
| ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg |
CXCR4 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg |
MAPK7 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg |
SorLA Blocking Peptide for Immunocompetition, Immunodepletion
|
inquiry |
| ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg |
EDG8 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1266 | ROR1 Blocking Peptide (AC1266) | 250 µg |
ROR1 Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
| ACPP-1267 | Acrp30 Mouse, Trimeric (AC1267) | 2 µg |
Adiponectin Mouse Recombinant, Trimeric form
|
inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg |
Galectin-3 Human Recombinant
|
inquiry |
| ACPP-1269 | Mouse GDNF Protein (AC1269) | 2 µg |
Glial-Derived Neurotrophic Factor Mouse Recombinant
|
inquiry |
| ACPP-1270 | Luteinizing Hormone Blocking Peptide (AC1270) | 250 µg |
Luteinizing Hormone Blocking Peptide for Immunodepletion, Immunocompetition
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.